Teva Pharmaceutical Jumps On Lipitor Market Share Increase And CEO Appointment
Teva Pharmaceutical (NASDAQ:TEVA) rose to its highest level in almost six months on news that Ranbaxy Laboratories picked up market share in with its Lipitor drug, as well as news that the firm's choice of CEO was well received by analysts. Shares of Teva rose 3.3% to $43.16 in Tel Aviv trading on the news following yesterday's 6.8% rise in US trading. Teva Pharmaceutical Industries (NASDAQ:TEVA) has potential upside of 27.6% based on a current price of $43.1 and an average consensus analyst pri ...
Ranbaxy Laboratories Videos.
